Domov › Uroteliálny (prechodnobunkový) karcinóm › Illinois
Klinické štúdie Uroteliálny (prechodnobunkový) karcinóm v štáte Illinois
21 štúdií pre Uroteliálny (prechodnobunkový) karcinóm hľadá účastníkov v zariadeniach v štáte Illinois.
Mestá v štáte Illinois
Oficiálny text štúdie (anglicky)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #26, Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- University of Illinois, Chicago
- Carle at The Riverfront, Danville
- Cancer Care Specialists of Illinois - Decatur, Decatur
- a 13 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06524544Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
- Southern Illinois University, Springfield
Prebieha nábor
Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06262516Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Hope and Healing Clinical Research LLC, Hinsdale
- Hope and Healing Clinical Research LLC, New Lenox
- Illinois Cancer Specialists, Niles
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Carle at The Riverfront, Danville
- a 12 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Northwestern University, Chicago
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT05874921A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- University of Chicago Medical Center ( Site 1037), Chicago
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05562830Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Memorial Hospital, Shiloh
- Siteman Cancer Center - Shiloh, Shiloh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
- Endeavor Health, Evanston
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
- City of Hope - Chicago, Zion
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06293898Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Niles
- Research Site, Peoria
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07129993A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
- Accellacare - Deerfield, Deerfield
- a 5 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT04879329A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- The University of Chicago Medical Center - Oncology, Chicago
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT07169734Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
- COH Chicago, Zion
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT07484022Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-012 - University of Chicago, Chicago
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 11. 2025 · NCT03945162SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Prebieha náborObservačná štúdia
Vek 18 až 100 · Všetky pohlavia · Aktualizované 10. 10. 2025 · NCT06310759A Study of NX-1607 in Adults With Advanced Malignancies
- University of Chicago, Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT05107674CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Northwestern University, Chicago
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 3. 2023 · NCT05733000Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.